BIO - Bio-Rad Labs Non-GAAP EPS of $3.00 beats by $0.32 revenue of $681.11M misses by $14.72M

2023-08-03 16:47:10 ET

• Bio-Rad Labs press release ( NYSE: BIO ): Q2 Non-GAAP EPS of $3.00 beats by $0.32 .
• Revenue of $681.11M (-1.4% Y/Y) misses by $14.72M .
• Updated 2023 Outlook: The company currently expects non-GAAP currency-neutral revenue growth of approximately 0.8 percent in 2023 compared to its previous estimate of 4.5 percent and an estimated non-GAAP operating margin of about 16.0 percent versus the company’s prior estimate of approximately 17.5 percent. Excluding COVID-related sales, Bio-Rad estimates full-year 2023 non-GAAP currency-neutral revenue growth to be about 4.5 percent compared to its prior expectation of approximately 8.5 percent.

For further details see: